Vitreomacular Interface Abnormalities in Diabetic Retinopathy Using OCT

NCT03686436 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-01-17

No results posted yet for this study

Summary

to evaluate vitreomacular interface abnormalities in diabetic retinopathy by using Ocular Coherence Tomography (OCT)

Conditions

  • on Vitreomacular Interface Abnormalities in Diabetic Retinopathy

Interventions

DEVICE

ocular coherence tomography

imaging by ocular coherence tomography

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • abdalnaser kamil · Asiut university

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-02-01
Completion
2021-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686436 on ClinicalTrials.gov